volume 58, issue 1, P39-47 2021
DOI: 10.1590/s0004-2803.202100000-08
View full text
|
Sign up to set email alerts
|
Share
Maria Clara Freitas COELHO,
Henrique Gomes RIBEIRO,
Celio Geraldo de Oliveira GOMES
et al.

Abstract: ABSTRACT BACKGROUND: H. pylori chronic atrophic gastritis is a premalignant lesion, and its staging, according to OLGA and OLGIM systems aims to identify patients at increased risk of developing gastric cancer and optimize their follow-up. GastroPanel®, serum biomarkers panel including pepsinogen I (PGI), pepsinogen II (PGII), Gastrin 17 (G17) and anti- H. pylori antibodies is a noninvasive test for adenocarcinoma risk assessment in chronic H. pylori gastritis patients. OBJECTIVE: Prospective study to evalu…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals